Ardelyx Inc (NAS:ARDX)
$ 4.905 -0.165 (-3.25%) Market Cap: 1.16 Bil Enterprise Value: 1.11 Bil PE Ratio: 0 PB Ratio: 7.32 GF Score: 75/100

Ardelyx Inc to Discuss Launching IBSRELA Second Quarter of 2022 Call Transcript

Nov 30, 2021 / 01:00PM GMT
Release Date Price: $1.14 (+32.24%)
Operator

Good morning, and welcome to Ardelyx's conference call. (Operator Instructions) Session after the prepared remarks. As a reminder, today's call is being recorded. I would now like to turn the call over to Justin Renz, Chief Financial Officer of Ardelyx. You may begin.

Justin A. Renz
Ardelyx, Inc. - CFO & CAO

Thank you, and good morning, everyone. During this call, we will refer to the press release we issued earlier today, which is available in the Investors section of the company's website at ardelyx.com. On the call with me today are Mike Raab, President and CEO; and David Rosenbaum, our Chief Development Officer; Susan Rodriguez, our Chief Commercial Officer; and Dr. William Chey, Nostrant Professor of Medicine at the University of Michigan School of Medicine. A thought with Gastroenterologists, who will share some prepared remarks. Dr. Laura Williams, our Chief Medical Officer, will also join us for the question-and-answer period.

During this call, we will be making forward-looking statements that are subject to risks and uncertainties. Our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot